Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Top Ten most popular articles on Pharmafile.com this week

October 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, biosimilars. GSK, manufacturing, pharma, top 10

Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …
News

Trevena’s opioid injection fails to win over FDA committee

October 12, 2018 Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma

Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …
News

Living with Langerhans Cell Histiocytosis

October 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Langerhans Cell Histiocytosis, feature. pharma, patient experience, rare diseae

Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout …
Feature

Celltrion’s Rituxan biosimilar gets unanimous backing from FDA committee

October 11, 2018 Sales and Marketing FDA, Oncologic Drugs Advisory Committee, Rituxan, Roche, Truxima

FDA approval looks to be in reach for Celltrion, as an advisory committee for the US regulator voted unanimously to …
News

Trump signs trust-busting biosimilar bill into law

October 11, 2018 Business Services, Sales and Marketing FTC, Trump, biosimilars, generics, us politics

President Donald J Trump has signed off a law which requires drugmakers and pharma firms to reveal the details of …
News

NICE recommends first new X-linked hypophosphataemia therapy in over 30 years

October 10, 2018 Research and Development, Sales and Marketing Crysvita, Kyowa Kirin International, NHS, NICE, X-linked hypophosphataemia, pharma

NICE has announced its evidence-based recommendation that Kyowa Kirin International’s Crysvita (burosumab) be made available on the NHS for the …
News

Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO

October 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals

Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …
Appointment

The economics of mental health

October 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …
Feature

NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia

October 8, 2018 Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma

NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …
News

NIHR whitepaper claims UK needs High Throughput Centres after Brexit

October 8, 2018 Sales and Marketing NHS, NIHR, UK, clinical trials, phase III

The National Institute for Health Research (NIHR) has released a new whitepaper outlining the substantial benefits NHS High Throughput Centres …
News

Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership

October 8, 2018 Research and Development, Sales and Marketing Alzheimer's, pharma, tencent

Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …
News

US FDA approves HPV vaccine for men and women aged 27-45

October 8, 2018 Sales and Marketing CDC, Cancer, FDA, HPV, approval, infectious diseases, vaccines

The US Food and Drug Administration have approved the use of HPV vaccine Gardasil 9 for both men and woman …
News

MSD signs $117m deal with Samsung Bioepis over Janssen biosimilar

October 8, 2018 Sales and Marketing Biogen, Janssen, MSD, Samsung, Samsung Bioepis

American multinational MSD have won a $117 million contract allowing them to supply Samsung Bioepis’ Renflexis to the US Department …
News

Top Ten most popular articles on Pharmafile.com this week

October 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10

As September came to a close and October began the UK was hit hard in the headlines after American firm …
News

FDA expands indication of Roche’s Hemlibra in haemophilia

October 5, 2018 Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma

The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026